| Bioactivity | DHX9-IN-16 (208) is a RNA helicase DHX9 inhibitor, with an EC50 of 0.125 μM in DHX9 cellular target engagement. Used in cancer research[1]. |
| Name | DHX9-IN-16 |
| CAS | 2973397-48-5 |
| Formula | C19H20ClN5O4S |
| Molar Mass | 449.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Matthew H, et al.Matthew H, et al. Inhibitors of rna helicase dhx9 and uses thereof. Patent WO2023154519. Inhibitors of rna helicase dhx9 and uses thereof. Patent WO2023154519. |
DHX9-IN-16
CAS: 2973397-48-5 F: C19H20ClN5O4S W: 449.91
DHX9-IN-16 (208) is a RNA helicase DHX9 inhibitor, with an EC50 of 0.125 μM in DHX9 cellular target engagement. Used in
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.